Jessica A. Bell
Senior Director, Global Biological Policy and Programs
In preparation for the Fall 2021 launch of the second Global Health Security (GHS) Index, members of the GHS Index International Panel of Experts are reviewing the index framework, discussing indicator weighting strategies, and assessing how the 2019 GHS Index compared to real-world outcomes of preparedness and mitigation in the context of the COVID-19 pandemic.
At virtual meetings in April, panel members discussed the importance of laboratory capacity, contact tracing, and political risks in expanding and weighting the pandemic-conscious report. Members underscored that despite the unpredictability of a pandemic still in progress, the 2021 GHS Index will incorporate important lessons learned from COVID-19 and will continue as an international benchmark for capacity and capability in times of global disaster.
The GHS Index is an NTI | bio project in partnership with the Johns Hopkins Center for Health Security and The Economist Intelligence Unit. It serves as a tool for identifying gaps in national-level preparedness and illustrates the need for capacity development across major health security categories. In its inaugural edition in 2019, the GHS Index indicated that no country was sufficiently prepared for an epidemic or pandemic.
For more information about the GHS Index, visit: www.ghsindex.org
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI joined governments and organizations from around the world for the 2nd Global COVID-19 Summit on May 12, 2022 and committed to provide $35,000 to the pandemic preparedness and global health security financial intermediary fund.
Report calls on national and global leaders to sustain and expand upon preparedness capacities developed to fight COVID-19
NTI submitted a statement to the virtual COVID-19 Summit convened by President Biden, calling for bold, decisive action to stem the devastating impacts of COVID-19 globally.